Previous close | 9.75 |
Open | 9.50 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 9.50 - 9.75 |
52-week range | 1.90 - 44.50 |
Volume | |
Avg. volume | 11 |
Market cap | 85.9M |
Beta (5Y monthly) | 1.04 |
PE ratio (TTM) | N/A |
EPS (TTM) | -20.66 |
Earnings date | 13 May 2024 - 17 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
BOCA RATON, Fla., March 29, 2024--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023.
BOCA RATON, Fla., November 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the third quarter ended September 30, 2023.
BOCA RATON, Fla., August 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the second quarter ended June 30, 2023.